Acorda to buy Finland's Biotie for $363 million: Reuters
U.S. biotechnology company Acorda Therapeutics Inc. (ACOR.O) announced on Tuesday an agreed $363 million cash bid for all of the shares in Finland's Biotie Therapies, Reuters News reported.
19 January 2016•1 min read
